1 diciembre 2014
A biomarker that is strongly associated with triple negative breast cancer, a highly aggressive carcinoma that often has early relapse and metastasis following chemotherapy, has been found by researchers. The newly identified biomarker, a gene called RASAL2, provides a target for developing new therapeutics designed to treat this often deadly disease.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/y1EV_U1HCr8/141201113408.htm
